Maximus (NYSE:MMS) Sets New 52-Week High at $92.86

Maximus, Inc. (NYSE:MMSGet Free Report) reached a new 52-week high on Friday . The company traded as high as $92.86 and last traded at $92.45, with a volume of 7450 shares traded. The stock had previously closed at $91.65.

Maximus Stock Performance

The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.63. The business has a 50 day moving average price of $87.05 and a two-hundred day moving average price of $83.95. The stock has a market cap of $5.64 billion, a P/E ratio of 24.06 and a beta of 0.75.

Maximus (NYSE:MMSGet Free Report) last released its quarterly earnings data on Wednesday, May 8th. The health services provider reported $1.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.26. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 4.58% and a return on equity of 18.02%. The company’s quarterly revenue was up 11.7% on a year-over-year basis. During the same period last year, the firm earned $0.80 earnings per share. On average, sell-side analysts forecast that Maximus, Inc. will post 5.79 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Thursday, August 15th. Maximus’s dividend payout ratio (DPR) is presently 31.50%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rise Advisors LLC raised its position in Maximus by 1,445.0% during the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock worth $26,000 after acquiring an additional 289 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares during the last quarter. Blue Trust Inc. increased its position in Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock worth $33,000 after purchasing an additional 262 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new position in Maximus during the fourth quarter worth approximately $52,000. Finally, Planned Solutions Inc. acquired a new position in Maximus during the fourth quarter worth approximately $59,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Company Profile

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.